Keyphrases
Atrial Fibrillation
100%
Antithrombotic Therapy
100%
Stroke Prevention in Atrial Fibrillation
100%
Asia
85%
Warfarin
57%
Intracranial Hemorrhage
28%
Stroke Risk
28%
Disease Burden
28%
Preventing Stroke
28%
Hypertension
14%
Clinical Practice Guidelines
14%
Clinical Practice
14%
Effective Means
14%
Aging Population
14%
Asian Patients
14%
Early Detection
14%
Patients at Risk
14%
Health Care Costs
14%
Anticoagulants
14%
Awareness Campaign
14%
Atrial Fibrillation Treatment
14%
Antiplatelet Agents
14%
Oral Anticoagulants
14%
Oral Anticoagulation
14%
Bleeding Risk
14%
Factor Xa Inhibitors
14%
Direct Thrombin Inhibitors
14%
Vitamin K Antagonists
14%
Stroke Burden
14%
Evidence-based Pharmacotherapy
14%
Heart Arrhythmia
14%
Suboptimal Control
14%
Atrial Fibrillation-related Stroke
14%
Life-threatening Bleeding
14%
Atrial Fibrillation Risk
14%
Undertreated
14%
Intracranial Bleeding
14%
Direct Oral Anticoagulants
14%
Health Crisis
14%
Underuse
14%
Oral Anticoagulant Drugs
14%
Medicine and Dentistry
Apoplexy
100%
Atrial Fibrillation
100%
Antithrombotic
100%
Warfarin
33%
Cerebral Hemorrhage
25%
Disease Burden
16%
Drug Therapy
8%
Health Care Cost
8%
Cardiac Dysrhythmia
8%
Bleeding
8%
Awareness
8%
Anticoagulation
8%
Antiplatelet Drug
8%
Antithrombotic Therapy
8%
Vitamin K Antagonist
8%
Direct Thrombin Inhibitor
8%
Asia Population
8%
Anticoagulant
8%
Blood Clotting Factor 10a Inhibitor
8%
Neuroscience
Antithrombotic
100%
Cerebrovascular Accident
100%
Atrial Fibrillation
100%
Warfarin
33%
Cerebral Hemorrhage
25%
Cardiac Dysrhythmia
8%
Vitamin K Antagonist
8%
Blood Clotting Factor 10a
8%
Antiplatelet Drug
8%
Direct Thrombin Inhibitor
8%
Hypertension
8%
Drug Therapy
8%